Cargando...
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
PURPOSE: Anticoagulant therapy for at least 3–6 months is currently recommended for treatment of venous thromboembolism (VTE) in patients with cancer, but the optimal duration of treatment is unknown. This study examines the association between the duration of anticoagulation treatment and VTE recur...
Gardado en:
| Publicado en: | Support Care Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726708/ https://ncbi.nlm.nih.gov/pubmed/30734088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-4661-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|